Primary Fetal Lung Hypoplasia (PFLH): Imaging and Clinical Characteristics

Reuven Achiron1,2, Yinon Gilboa1,2, Yishay Salem3,2

  • 1Obstetrics and Gynecology, Sheba Medical Center Tel-Hashomer, Ramat Gan, Israel.

Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|June 15, 2017
PubMed

Insights

Primary fetal lung hypoplasia (PFLH) is a rare, often lethal condition. Bilateral PFLH is typically fatal, while unilateral PFLH has a variable prognosis depending on associated anomalies.

Area of Science:

  • Medical Imaging
  • Pediatric Pathology
  • Fetal Medicine

Background:

  • Primary fetal lung hypoplasia (PFLH) is a rare congenital anomaly.
  • Accurate diagnosis and prognostic assessment are crucial for affected neonates.

Purpose of the Study:

  • To characterize the in utero and postnatal imaging and clinical features of PFLH.
  • To identify key factors influencing the prognosis of PFLH.

Main Methods:

  • Retrospective review of 12 fetuses and neonates diagnosed with PFLH over an 11-year period.
  • Analysis of prenatal sonography, postnatal MRI, CTA, and histological findings.

Main Results:

  • 12 cases of PFLH identified: 4 bilateral and 8 unilateral (7 right, 1 left).
  • Bilateral PFLH cases had poor outcomes (termination or early death).
  • Unilateral right PFLH cases frequently associated with Scimitar syndrome (5/7) and gastrointestinal tract anomalies (2/7).

Conclusions:

  • Bilateral PFLH is a lethal condition.
  • Unilateral PFLH prognosis varies, with associated anomalies like Scimitar syndrome and GIT issues being significant factors.
  • Evaluation of lung vascularity and associated anomalies is critical for prognosis in PFLH.